Inger Sandlie

Director/Board Member at

Radiumhospitalets Forskningsstiftelse

73 year

34 connections

Finance

Consumer Services

Health Technology

Profile

Inger Sandlie is the founder of Nykode Therapeutics ASA, founded in 2006, and Nextera AS, founded in 2009.
At Nextera AS, she held the title of Scientific Advisor.
Currently, Dr. Sandlie holds the position of Director at Radiumhospitalets Forskningsstiftelse and the title of Professor at the University of Oslo.

Inger Sandlie active positions

Companies	Position	Start
Radiumhospitalets Forskningsstiftelse Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Invests in companies from Nordic research institutions	Director/Board Member	-
University of Oslo University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Inger Sandlie

Former positions of Inger Sandlie

Companies	Position	End
NYKODE THERAPEUTICS	Founder	-
Nextera AS Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer	Founder	-

See the detail of Inger Sandlie's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Inger Sandlie's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Radiumhospitalets Forskningsstiftelse Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Invests in companies from Nordic research institutions	Finance
University of Oslo University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nykode Therapeutics ASA Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer	Health Technology
Nextera AS Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer	Commercial Services